Recent 52-Week High Exceeded in Shares of Pacific Biosciences of California (PACB)
Pacific Biosciences of California (NASDAQ:PACB) traded at a new 52-week high today of $4.38. Approximately 344,000 shares have changed hands today, as compared to an average 30-day volume of 380,000 shares.
Pacific Biosciences of California Inc. has developed a novel approach to studying the synthesis and regulation of DNA, RNA and protein. The Company's system enables real-time analysis of biomolecules with single molecule resolution.
In the past 52 weeks, shares of Pacific Biosciences of California have traded between a low of $1.06 and a high of $4.38 and are now at $4.16, which is 292% above that low price. In the last five trading sessions, the 50-day moving average (MA) has climbed 2.4% while the 200-day MA has risen 1.7%.
Pacific Biosciences of California (NASDAQ:PACB) is currently priced 36.6% above its average consensus analyst price target of $2.63. The stock should find initial support at its 50-day moving average (MA) of $2.92 and further support at its 200-day MA of $2.36.
SmarTrend recommended that subscribers consider buying shares of Pacific Biosciences of California on May 28th, 2013 as our proprietary SmarTrend analytics indicated a new Uptrend was in progress when shares hit $2.70. Since that recommendation, shares of Pacific Biosciences of California have risen 49.9%. We continue to monitor PACB for any potential shift so investors can protect gains and will alert SmarTrend subscribers immediately.
Keywords: 52 week high/lows pacific biosciences of california